Engagement of the private pharmaceutical sector for TB control: rhetoric or reality?

The following two tabs change content below.


Posts by "GHHub" are curated by our group of volunteer editors. For more information please visit our "about us" page.
The paper draws upon the efforts made by TB programs with broader implications for antimicrobial resistance and pharmaceutical policy. The paper highlights two key messages:
  • Although private pharmacies are willing and able to contribute to TB control efforts, interventions have not scaled adequately. Coverage ranged from less than 5% to 9% of the universe of private pharmacies, which is unlikely to have broader public health impact (figure 1 in paper)
  • The institutional roles of national medicines regulatory authorities, national pharmacy associations, private pharmacy and wholesaler associations and pharmacy schools need to be better utilized (figure 2 in paper)

Read more here: https://goo.gl/7QEegK